Search company, investor...
Practice Point company logo

Practice Point

Founded Year



Acquired | Acquired

About Practice Point

Practice Point provider of veterinary practice management software in the UK including the firm's flagship Assisi Veterinary system.On August 11th, 2020, Practice Point was acquired by ClearCourse, terms of the transaction were not disclosed.

Headquarters Location

Crewe, England,

United Kingdom

Missing: Practice Point's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: Practice Point's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Expert Collections containing Practice Point

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Practice Point is included in 1 Expert Collection, including Digital Health.


Digital Health

13,118 items

Technologies, platforms, and systems that engage consumers for lifestyle, wellness, or health-related purposes; capture, store, or transmit health data; and/or support life science and clinical operations. (DiME, DTA, HealthXL, & NODE.Health)

Latest Practice Point News

More than half of VA rheumatologists remain skeptical of telemedicine for new patients

Feb 22, 2022

Disclosures: Singh reports support through a Veterans Affairs Health Services Research and Development Award, as well as consulting fees from Crealta/Horizon, Medisys, Fidia, PK Med, Two Labs Inc., Adept Field Solutions, Clinical Care Options, Clearview Healthcare Aartners, Putnam Associates, Focus Forward, Navigant Consulting, Spherix, MedIQ, Jupiter Life Science, UBM LLC, Trio Health, Medscape, WebMD, Practice Point Communications, the NIH and the American College of Rheumatology; institutional research support from Zimmer Biomet Holdings; food and beverage payments from Intuitive Surgical Inc./Philips Electronics North America; stock options in TPT Global Tech, Vaxart Pharmaceuticals, Atyu Biopharma, Adaptimmune Therapeutics, GeoVax Labs, Pieris Pharmaceuticals, Enzolytics Inc., Seres Therapeutics, Tonix Pharmaceuticals Holding Corp. and Charlotte’s Web Holdings, Inc.; speaking fees from Simply Speaking; executive membership with Outcomes Measures in Rheumatology (OMERACT); and arms-length funding from eight companies. Please see the study for all other authors’ relevant financial disclosures. ADD TOPIC TO EMAIL ALERTS Receive an email when new articles are posted on Please provide your email address to receive an email when new articles are posted on . Please try again later. If you continue to have this issue please contact . Back to Healio Despite their increasing comfort with video and telemedicine visits during the COVID-19 pandemic, most rheumatologists at the U.S. Department of Veterans Affairs remain skeptical of the technology’s use for new patients, according to data. “A survey of VA rheumatology providers early in the pandemic April-May 2020 found that most providers were comfortable providing virtual care to established stable patients with autoimmune and inflammatory rheumatic diseases (AIIRD) and a significantly smaller proportion to new patients or those with active disease,” Jasvinder A. Singh, MBBS, MPH, of the Birmingham VA Medical Center and the University of Alabama at Birmingham, and colleagues wrote. Despite their increasing comfort with remote visits during the COVID-19 pandemic, VA rheumatologists remain skeptical of the technology’s use for new patients, according to data. Source: Adobe Stock “In June/July 2020 many VA health care centers reopened their facilities to in-person visits but at limited capacity,” they added. “It was thus timely to repeat the national VA rheumatology provider survey to evaluate provider resilience and changes in providers’ view of telemedicine and their comfort with it in managing patients with AIIRD.” To analyze the experience and practices of rheumatologists at VA facilities, as well as their views on outpatient management, and assess provider resilience with various modes of outpatient care, Singh and colleagues performed a follow-up cross-sectional survey among members of the VA Rheumatology Consortium. Jasvinder A. Singh Conducted via email from November 2020 to January 2021, the updated survey asked providers their opinions on the best health care delivery modes for rheumatology, which diseases are appropriate for telephone or video visits, and their own use and comfort with remote-visit technologies. Also included were new questions on laboratory monitoring for high-risk medication toxicity. Meanwhile, the researchers measured provider resilience — or the ability to cope with stress — using a validated two-item Connor-Davidson Resilience Scale (CD-RISC2), scored from zero to eight, with higher scores corresponding to higher resilience. According to the researchers, the general population mean score ranges from 5.9 to 6.9, while the mean among physicians is 6.5. Among 143 eligible members of the VA Rheumatology Consortium across the United States, a total of 114 responded to the follow-up survey. Of these participants, 64 reported that they had responded to the original VA COVID-19 survey. According to the researchers, who published their findings in The Journal of Rheumatology, fewer VA rheumatologists reported using telephone visits — 78% versus 91% (P = .009) — with more using clinical video telehealth (CVT) — 16% versus 7% (P = .04) — or in-person visits — 76% versus 59% (P = .007) — compared with the original survey. Most responders reported that they were somewhat or very comfortable with the quality of visits for established, but not new, patients for telephone, video-based VA video connect (VVC), and CVT. The mean CD-RISC2 score was 6.8 (standard deviation = 1.11), “significantly higher” than the original survey score of 6.35 (SD = 1.26) (P = .004), the researchers wrote. After adjusting for age, sex and ethnicity, high physician resilience was associated with significantly higher ORs for comfort with technology (1.71; 95% CI, 0.67-4.4) and the quality of VVC visits (4.13; 95% CI, 1.49-11.44) for established patients. High resilience was similarly associated with higher ORs for new patients — 2.79 (95% CI, 1.11-7.05) and 2.69 (95% CI, 1.06-6.82), respectively. “Despite greater than 6 months experience with telemedicine, providers continued to have reservations with its utilization for new patients and specific AIIRD subpopulations,” Singh and colleagues wrote. “Greater technology education for patients and providers, and more ancillary staff support to providers, could improve the acceptance of telemedicine and its appropriate use ,” they added. “The knowledge of barriers to the use of technology in providing optimal rheumatology care, and the association of provider resilience with comfort with telemedicine, can inform health care policymakers and allow delivery of optimal health care to patients with rheumatic diseases in one of the largest integrated healthcare systems in the U.S.” Read more about

Practice Point Frequently Asked Questions (FAQ)

  • When was Practice Point founded?

    Practice Point was founded in 2011.

  • Where is Practice Point's headquarters?

    Practice Point's headquarters is located at Crewe.

  • What is Practice Point's latest funding round?

    Practice Point's latest funding round is Acquired.

  • Who are the investors of Practice Point?

    Investors of Practice Point include ClearCourse.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.